Literature DB >> 22135848

Biochemia Medica introduces the revised policy on statement of conflict of Interest.

Ana-Maria Simundic.   

Abstract

Biochemia Medica announces that from this issue Journal will be publishing the Statement on Conflict of Interest for Authors for all article types in printed as well as in electronic form of the Journal. This way Journal wishes to provide its readers the opportunity to unambiguously judge the quality and reliability of the data presentation and potential competing interests that could have biased the quality of the presented work in any way. This decision was made because we believe that scientific journals have an ultimate responsibility to provide unbiased scientific articles to its readership. We also believe that if any potential source of bias exists, it is the responsibility of the journal to disclose this information, since this might influence the judging the manuscript by editors, reviewers and readers. Therefore, when submitting their work in the future, author are kindly invited to make sure that they have carefully considered and disclosed all potential sources of competing interests that might have influenced their work. We hope that in such way we can help build a better future for the evidence based scientific research, on an international level.

Mesh:

Year:  2011        PMID: 22135848     DOI: 10.11613/bm.2011.017

Source DB:  PubMed          Journal:  Biochem Med (Zagreb)        ISSN: 1330-0962            Impact factor:   2.313


  3 in total

1.  Biochemia Medica indexed in Medline.

Authors:  Ana-Maria Simundic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

2.  Bias in research.

Authors:  Ana-Maria Simundić
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

3.  News at Biochemia Medica: research integrity corner, updated guidelines to authors, revised author statement form and adopted ICMJE Conflict-of-Interest Form.

Authors:  Ana-Maria Simundic
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.